We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-25.33%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$293M
AUM Growth
+$14.4M
Cap. Flow
+$92.4M
Cap. Flow %
31.57%
Top 10 Hldgs %
46.52%
Holding
48
New
20
Increased
10
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$23M
2
INVA icon
Innoviva
INVA
+$18.2M
3
FRPT icon
Freshpet
FRPT
+$16.2M
4
VNCE icon
Vince Holding Corp
VNCE
+$12.7M
5
SPNC
Spectranetics Corp
SPNC
+$11.2M

Top Sells

Rank Stock Value
1
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$30.3M
2
TBPH icon
Theravance Biopharma
TBPH
+$12.7M
3
QLGC
QLOGIC CORP
QLGC
+$11.5M
4
FTD
FTD Companies, Inc. Common Stock
FTD
+$8.02M
5
LPCN icon
Lipocine
LPCN
+$7.29M

Sector Composition

Rank Sector Weight
1 Healthcare 42.14%
2 Consumer Discretionary 16.58%
3 Industrials 6.18%
4 Consumer Staples 4.02%
5 Financials 3.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$19.2M 6.54%
100,000
-50,000
-33% -$10.1M
GSK icon
2
CALL
GSK
GSK
$104B
$15.4M 5.25%
+320,000
New +$16.7M
PTX
3
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$15.2M 5.18%
+480,000
New +$23M
INVA icon
4
Innoviva
INVA
$1.6B
$14.7M 5.03%
+1,341,000
New +$18.2M
ATRS
5
DELISTED
Antares Pharma, Inc.
ATRS
$14.1M 4.82%
8,300,000
+1,900,000
+30% +$3.72M
KODK icon
6
Kodak
KODK
$750M
$12.6M 4.29%
804,000
-156,000
-16% -$2.33M
FRPT icon
7
Freshpet
FRPT
$2.78B
$11.8M 4.02%
+1,120,000
New +$16.2M
XNPT
8
DELISTED
XENOPORT, INC.
XNPT
$11.6M 3.95%
3,330,000
+1,730,000
+108% +$10.9M
ACOR
9
DELISTED
Acorda Therapeutics
ACOR
$11.1M 3.78%
3,483
+1,933
+125% +$7.5M
AVTA
10
DELISTED
Avantax, Inc. Common Stock
AVTA
$10.7M 3.67%
780,000
+80,000
+11% +$1.15M
BDBD
11
DELISTED
BOULDER BRANDS INC
BDBD
$10.4M 3.54%
+1,266,000
New +$10.1M
PBY
12
DELISTED
PEP BOYS MANNY MOE& JACK
PBY
$10.2M 3.5%
+840,000
New +$9.91M
APOL
13
DELISTED
Apollo Education Group Inc Class A
APOL
$9.73M 3.32%
880,000
-390,000
-31% -$4.78M
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$327M
$8.57M 2.93%
760,000
-382,000
-33% -$4.67M
BDSI
15
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.23M 2.81%
1,480,000
+1,080,000
+270% +$7.97M
RXDX
16
DELISTED
Ignyta, Inc.
RXDX
$8.2M 2.8%
934,000
+64,000
+7% +$918K
GMCR
17
DELISTED
KEURIG GREEN MTN INC
GMCR
$8.03M 2.74%
+154,000
New +$9.48M
TVTY
18
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$7.81M 2.67%
702,000
+62,000
+10% +$757K
FPRX
19
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7.79M 2.66%
+506,000
New +$10.9M
SPNC
20
DELISTED
Spectranetics Corp
SPNC
$7.36M 2.51%
+624,000
New +$11.2M
LVS icon
21
Las Vegas Sands
LVS
$30.1B
$7.21M 2.46%
+190,000
New +$9.58M
DECK icon
22
Deckers Outdoor
DECK
$14.8B
$6.97M 2.38%
+720,000
New +$8.03M
JCP
23
DELISTED
J.C. Penney Company, Inc.
JCP
$6.88M 2.35%
740,000
+240,000
+48% +$2.13M
DFRG
24
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$5.86M 2%
+422,000
New +$6.42M
FTD
25
DELISTED
FTD Companies, Inc. Common Stock
FTD
$5.54M 1.89%
186,000
-272,000
-59% -$8.02M
1
2

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Armistice Capital held 48 positions worth $293M, up 5.2% from $278M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Armistice Capital deployed $92.4M of net new capital in Q3 2015, opening 20 new positions and adding to 10 existing holdings. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 480,000 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was FTD Companies, Inc. Common Stock, an estimated $8.02M trimmed.

  • Armistice Capital's largest Q3 2015 buy was Pernix Therapeutics Holdings, Inc.: 480,000 shares worth $15.2M.
  • Armistice Capital added most to XENOPORT, INC. in Q3 2015, an estimated $10.9M increase.
  • Armistice Capital's biggest Q3 2015 reduction was FTD Companies, Inc. Common Stock, cutting an estimated $8.02M.
  • Armistice Capital fully exited Spectrum Pharmaceuticals Inc in Q3 2015, selling an estimated $30.3M.
  • Armistice Capital's ten largest holdings make up 47% of its $293M portfolio in Q3 2015.
  • Armistice Capital opened 20 new positions and closed 9 in Q3 2015.
  • Armistice Capital's portfolio value rose 5.2% quarter-over-quarter to $293M.

Based on Armistice Capital's 13F filing for Q3 2015, filed 16 Nov 2015.